| Dr Brooke Eileen Flesher, AUD | |
|
9000 W Wisconsin Ave Ste B340, Milwaukee, WI 53226-4874 | |
| (414) 266-5725 | |
| (414) 266-6189 |
| Full Name | Dr Brooke Eileen Flesher |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 9000 W Wisconsin Ave Ste B340, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033761846 | NPI | - | NPPES |
| 1033761846 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 693-156 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brooke Eileen Flesher, AUD 9000 W Wisconsin Ave # Ms 958, Milwaukee, WI 53226-4874 Ph: (414) 266-7615 | Dr Brooke Eileen Flesher, AUD 9000 W Wisconsin Ave Ste B340, Milwaukee, WI 53226-4874 Ph: (414) 266-5725 |
News Archive
Current UK procedures to screen new immigrants for tuberculosis (TB) fail to detect more than 70 per cent of cases of latent infection, according to a new study published in The Lancet Infectious Diseases.
NewCardio, Inc., a cardiac diagnostic technology provider, announced today that a U.S.-based CRO that provides early phase and specialty clinical drug development services to the pharmaceutical industry, has signed an MSA, licensing NewCardio's QTinno⢠software solution in order to deliver fully automated cardiac safety analysis in early phase QT studies.
Birth control pills are an effective and safe form of birth control; however, they are associated with a number of side effects, including mood alterations.
In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable angina), use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 (believed to play a role in the development of atherosclerosis) did not reduce the risk of recurrent major coronary events, according to a study published by JAMA.
Roche announced today at the 51st Meeting of the American Society of Hematology (ASH) in New Orleans, LA (USA) that the pivotal Phase III study CLL8 showed that patients with previously-untreated chronic lymphocytic leukemia (CLL) survived their disease longer when treated with Rituxan (rituximab) compared to chemotherapy alone.
› Verified 2 days ago
Dr. Kya Elizabeth Hulse, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave # B340, Milwaukee, WI 53226 Phone: 414-266-2934 | |
Dr. Christina L Runge, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9200 W Wisconsin Ave, Otolaryngology, Milwaukee, WI 53226 Phone: 414-805-5562 Fax: 414-805-7936 | |
Mrs. Donna M Klawinski, MS CCCA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2741 W Layton Avenue Suite 206, Milwaukee, WI 53221 Phone: 414-281-9820 Fax: 414-281-9835 | |
Casey Wolter, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-266-2934 Fax: 414-266-6189 | |
Rachel Ann Lynch, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-266-2934 | |
Mr. John G Knox, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-3666 |